Sign inJoin waitlistJoin the waitlist

Mark Pimentel

Program Director, Medically Associated Science and Technology (MAST) Program · Cedars-Sinai Medical Center

Credentials: · ·

History

Medically Associated Science and Technology (MAST) Program · Cedars-Sinai Medical Center
Present

Gastroenterology
1995–1998
Internal Medicine
Cedars-Sinai Medical Center
1992–1995
Doctor of Medicine
1988–1992

Research

Rifaximin therapy for patients with irritable bowel syndrome without constipation
New England Journal of Medicine · 2011 · First of 11 authors · 750 citations
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
The American Journal of Gastroenterology · 2021 · 664 citations
Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus
The American Journal of Gastroenterology · 2017 · Last of 10 authors · 615 citations

Ali Rezaie
67 papers
Ruchi Mathur
52 papers
Ava Armani
18 papers
Christopher Chang
16 papers
JC
Jeffrey Conklin
16 papers
Anthony Lembo
12 papers
Henry Lin
12 papers
BB
Benjamin Basseri
10 papers · 9 as a fellow
ES
Edy Soffer
10 papers
Sandy Park
10 papers
WT
Will Takakura
10 papers · 10 as a fellow
LL
Laura Lai
9 papers

Clinical trials

Pilot of AbStats /AEGIS System for Detecting Motility Abnormalities
Principal investigator · Completed
Cedars-Sinai Medical Center
2013–2014
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Principal investigator · Completed
Mark Pimentel, MD
2009–2013
Rifaximin for the Treatment of Irritable Bowel Syndrome
Principal investigator · Completed · Phase 2
Cedars-Sinai Medical Center
2003–2007
Efficacy and Safety of Rifaximin With NAC in IBS-D
Study director · Completed · Phase 1, Phase 2
Cedars-Sinai Medical Center
2020–2022